Aurora Cannabis Inc vs JPMorgan Equity Premium Income ETF — how do they compare? Aurora Cannabis Inc trades at $3.63 (market cap $223.59M), while JPMorgan Equity Premium Income ETF trades at $57.79. The key difference: JPMorgan Equity Premium Income ETF is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.
| ACB | JEPI | |
|---|---|---|
Market Cap | $223.59M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $6.23 | $59.88 |
52-Week Low | $2.58 | $55.29 |
Enterprise Value | $168.09M | — |
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $3.63, up 25.61% amid a hostile takeover bid from Curaleaf at a 45% premium. The stock shows mixed signals with a neutral technical outlook, while fundamentals reveal revenue growth to $343.29M in 2025 but a net income margin of -38.25% and negative ROE. Cash flow improved to a net positive $1.83M in 2025, though 2026 projections indicate renewed losses.
The takeover offer presents a near-term catalyst, but standalone risks persist including profitability challenges and competitive pressures. Analysts are cautious with a majority hold rating. Investors face a binary outcome: accept the premium bid or navigate ACB's volatile fundamentals.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →